Single-cell RNA sequencing has shown age-related activation of the macrophage pyroptosis pathway, which accelerates stromal cell senescence and reproductive decline (Zhou C
The key is to know: there isnt only one way to fight pigment spots
Researchers continue to use the blend as a convenience pre-mix in dual-mechanism research protocols and as a screening compound for healing-peptide pharmacology research
December 15, 2025: Study Shows that Zepbound May Not Reduce the Risk of Obesity-Related Cancers Earlier this year, researchers suggested that Zepbound, which many people take to lose weight, could lower someones risk of thirteen different obesity-related cancers
Vienna: R Foundation for Statistical Computing
5 Market outlook Eli Lillys oral non-peptide GLP-1RA orforglipron is advancing through the ACHIEVE Phase III program, with Lilly signaling regulatory submissions for obesity in 2025 and type 2 diabetes in 2026, following positive results from both Phase 2 obesity (GZGI) and Phase 3 T2DM (ACHIEVE-1) trials